Literature DB >> 8023099

[Simultaneous occurrence of breast carcinoma and malignant lymphoma. Case observations and literature review].

B M Frey1, R Morant, H J Senn, T Fisch, U Schmid.   

Abstract

Based on the observation of 5 patients with simultaneous breast cancer and malignant lymphoma, we discuss the phenomenon of synchronicity of two different tumors in the same individual. Synchronicity of malignancy is rare and could point to a genetic predisposition (family history) or common environmental influence in generating cancer. In elderly patients, the appearance of multiple tumors may coincide by chance. In the case of synchronous or metachronous tumors it is essential to examine the new tumor manifestation by biopsy. In view of the therapeutic and prognostic implications, the second tumor should not be confused with a progression of the known primary malignancy.

Entities:  

Mesh:

Year:  1994        PMID: 8023099

Source DB:  PubMed          Journal:  Schweiz Med Wochenschr        ISSN: 0036-7672


  3 in total

Review 1.  Breast Cancer and Multiple Primary Malignant Tumors: Case Report and Review of the Literature.

Authors:  Alessandro De Luca; Federico Frusone; Massimo Vergine; Rosario Cocchiara; Giuseppe La Torre; Laura Ballesio; Massimo Monti; Maria Ida Amabile
Journal:  In Vivo       Date:  2019 Jul-Aug       Impact factor: 2.155

2.  Synchronous solid neuroendocrine breast carcinoma and abdominal lymphoma: A case report and review of the literature.

Authors:  Miguel Alonso-Ruano; Eugeni López-Bonet; Maria Victoria Huerta-Anaya; Ester Vila-Camps; Luis Bernadó; Francesc Tuca-Rodríguez; Pedro Suarez-Pumariega; Javier A Menendez
Journal:  Oncol Lett       Date:  2012-11-23       Impact factor: 2.967

3.  A rare case of non-invasive ductal carcinoma of the breast coexisting with follicular lymphoma: A case report with a review of the literature.

Authors:  Mikako Tamaoki; Yoshinori Nio; Kazuhiko Tsuboi; Marika Nio; Masashi Tamaoki; Riruke Maruyama
Journal:  Oncol Lett       Date:  2014-02-14       Impact factor: 2.967

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.